Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review.

Berebichez-Fridman R., Montero-Olvera PR.

Narrative Review, published in Sultan Qaboos Univ Med J (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Sultan Qaboos Univ Med J (2018)
Country
Oman
Reported sample size
—
Source database
PubMed
PMID
30607265
DOI
10.18295/squmj.2018.18.03.002

Abstract (original English)

First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem cells found throughout the body that share a fixed set of characteristics. Discovered initially in the bone marrow, this cell source is considered the gold standard for clinical research, although various other sources-including adipose tissue, dental pulp, mobilised peripheral blood and birth-derived tissues-have since been identified. Although similar, MSCs derived from different sources possess distinct characteristics, advantages and disadvantages, including their differentiation potential and proliferation capacity, which influence their applicability. Hence, they may be used for specific clinical applications in the fields of regenerative medicine and tissue engineering. This review article summarises current knowledge regarding the various sources, characteristics and therapeutic applications of MSCs.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Amniotic FluidBone MarrowBone Marrow CellsCell DifferentiationDental PulpFetal BloodHumansMesenchymal Stem Cell TransplantationMesenchymal Stem CellsReview Literature as Topic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.